Barclays Downgrades Amag Pharmaceuticals After 130% Rally From Lows By: TalkMarkets August 18, 2020 at 08:33 AM EDT Barclays analyst Balaji Prasad downgraded Amag Pharmaceuticals to Equal Weight from Overweight with an unchanged price target of $10. Read More >> Related Stocks: Amag Pharmaceuticals